An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213891
Company: RENATA

Products on ANDA 213891

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	AB	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213891

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/06/2022	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213891

FROVATRIPTAN SUCCINATE

TABLET;ORAL; EQ 2.5MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	211292	AMNEAL PHARMS CO
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	204730	GLENMARK PHARMS LTD
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	216998	LEADING
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	213891	RENATA

Top